Jim Cassella's Colleagues at Trevi Therapeutics
Jim Cassella's Contact Details
HQ
203-304-2499
203-304-2499
Location
Lexington, Massachusetts
Lexington, Massachusetts
Company
Trevi Therapeutics
Trevi Therapeutics
Jim Cassella's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Jim Cassella
Jim Cassella currently works for Trevi Therapeutics.
Jim Cassella's role at Trevi Therapeutics is Board Member.
Jim Cassella's email address is ***@trevitherapeutics.com. To view Jim Cassella's full email address, please signup to ConnectPlex.
Jim Cassella works in the BioTech/Drugs industry.
Jim Cassella's colleagues at Trevi Therapeutics are Anne VanLent, Farrell Simon, Jonathan Carlson, Pam Nieves, Paula Buckley, Christopher CPA, Rebecca Morse and others.
Jim Cassella's phone number is 203-304-2499